Zogenix is a global pharmaceutical company engaged in developing and commercializing therapies to improve the lives of patients and their families living with rare diseases. Co. is focused on developing and commercializing Fintepla, a low-dose fenfluramine, for pediatric epilepsy disorders and MT1621 for mitochondrial depletion disease, thymidine kinase 2 deficiency. In the United Kingdom, Fintepla is under late-stage development in Japan for the treatment of seizures associated with Dravet syndrome, a pediatric epilepsy disorder. Fintepla is also under late-stage development for the treatment of seizures associated with Lennox-Gastaut syndrome, another form of childhood-onset epilepsy. We show 28 historical shares outstanding datapoints in our ZGNX shares outstanding history coverage, used to compute ZGNX market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing ZGNX market cap history over the course of time is important for investors
interested in comparing ZGNX's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of ZGNX versus a peer is one thing; comparing
ZGNX market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like ZGNX can fluctuate over the course of history.
With this page we aim to empower investors researching ZGNX by allowing them to research the ZGNX market cap history. |
Free ZGNX Email Alerts:
Video: The Importance of Market Cap
